Literature DB >> 12808150

Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling.

Joe V Chakkalakal1, Mark A Stocksley, Mary-Ann Harrison, Lindsay M Angus, Julie Deschenes-Furry, Simon St-Pierre, Lynn A Megeney, Eva R Chin, Robin N Michel, Bernard J Jasmin.   

Abstract

Utrophin levels have recently been shown to be more abundant in slow vs. fast muscles, but the nature of the molecular events underlying this difference remains to be fully elucidated. Here, we determined whether this difference is due to the expression of utrophin A or B, and examined whether transcriptional regulatory mechanisms are also involved. Immunofluorescence experiments revealed that slower fibers contain significantly more utrophin A in extrasynaptic regions as compared with fast fibers. Single-fiber RT-PCR analysis demonstrated that expression of utrophin A transcripts correlates with the oxidative capacity of muscle fibers, with cells expressing myosin heavy chain I and IIa demonstrating the highest levels. Functional muscle overload, which stimulates expression of a slower, more oxidative phenotype, induced a significant increase in utrophin A mRNA levels. Because calcineurin has been implicated in controlling this slower, high oxidative myofiber program, we examined expression of utrophin A transcripts in muscles having altered calcineurin activity. Calcineurin inhibition resulted in an 80% decrease in utrophin A mRNA levels. Conversely, muscles from transgenic mice expressing an active form of calcineurin displayed higher levels of utrophin A transcripts. Electrophoretic mobility shift and supershift assays revealed the presence of a nuclear factor of activated T cells (NFAT) binding site in the utrophin A promoter. Transfection and direct gene transfer studies showed that active forms of calcineurin or nuclear NFATc1 transactivate the utrophin A promoter. Together, these results indicate that expression of utrophin A is related to the oxidative capacity of muscle fibers, and implicate calcineurin and its effector NFAT in this mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808150      PMCID: PMC164666          DOI: 10.1073/pnas.0932671100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Calcineurin Co-regulates contractile and metabolic components of slow muscle phenotype.

Authors:  X Bigard; H Sanchez; J Zoll; P Mateo; V Rousseau; V Veksler; R Ventura-Clapier
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 2.  Remodeling muscles with calcineurin.

Authors:  E N Olson; R S Williams
Journal:  Bioessays       Date:  2000-06       Impact factor: 4.345

3.  Role of intronic E- and N-box motifs in the transcriptional induction of the acetylcholinesterase gene during myogenic differentiation.

Authors:  L M Angus; R Y Chan; B J Jasmin
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

Review 4.  Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.

Authors:  T O Krag; M Gyrd-Hansen; T S Khurana
Journal:  Acta Physiol Scand       Date:  2001-03

5.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.

Authors:  E A Burton; J M Tinsley; P J Holzfeind; N R Rodrigues; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion.

Authors:  T Ort; S Voronov; J Guo; K Zawalich; S C Froehner; W Zawalich; M Solimena
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 7.  Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease.

Authors:  M W Berchtold; H Brinkmeier; M Müntener
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

8.  Calcineurin is required for skeletal muscle hypertrophy.

Authors:  S E Dunn; J L Burns; R N Michel
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

9.  Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter.

Authors:  F Galvagni; S Capo; S Oliviero
Journal:  J Mol Biol       Date:  2001-03-09       Impact factor: 5.469

10.  Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth.

Authors:  S E Dunn; E R Chin; R N Michel
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

View more
  42 in total

1.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

2.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 3.  Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise.

Authors:  Nathalie Koulmann; André-Xavier Bigard
Journal:  Pflugers Arch       Date:  2006-01-18       Impact factor: 3.657

4.  Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.

Authors:  Val A Fajardo; Paige J Chambers; Emma S Juracic; Bradley A Rietze; Daniel Gamu; Catherine Bellissimo; Frenk Kwon; Joe Quadrilatero; A Russell Tupling
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

Review 5.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

Review 6.  Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.

Authors:  Katja S C Röckl; Carol A Witczak; Laurie J Goodyear
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

7.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

Review 8.  The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-04-01

Review 9.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

Review 10.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.